top of page

Recent Posts

See All
September 2025 // News

Dr. Andrea Chicca, CEO, shares the highly promising results from Synendos Phase 1 Trials

 
 
October 2024 // News

Synendos Secures Innosuisse Funding to Advance Clinical Development of SYT-510

 
 
July 2024 // News

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch

 
 
bottom of page